A Phase 3 Trial of DT120 for Major Depressive Disorder (Ascend)
for Major Depressive Disorder
30 locations incl. Little Rock
Sponsor: Definium Therapeutics US, Inc.
Sex: All·Age: 18 - 74
Code: NCT07592689·Phase 3·Recruiting·Listed May 2026
Adams Clinical, Philadelphia
Clinical research site in Philadelphia, Pennsylvania · 9501 ROOSEVELT BLVD STE 208, PHILADELPHIA, PA 19114-1027 · (215) 676-6696 · Website
2.7on Google· View on Google Maps
As of September 2026, 9 paid clinical trials are recruiting at Adams Clinical, Philadelphia in Philadelphia, Pennsylvania. Active studies at this site cover conditions such as Major Depressive Disorder, Bipolar I Disorder and Schizophrenia. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
New trial at Adams Clinical, Philadelphia? We'll email you when one opens.
Recruiting clinical trials at Adams Clinical, Philadelphia (9)
Multicenter Study to Assess the Efficacy and Safety of LB-102 in the Treatment of Adult Patients With BP1MDE.
for Bipolar I Disorder
26 locations incl. Bentonville
Sponsor: LB Pharmaceuticals Inc.
Sex: All·Age: 18 - 65
Code: NCT07494305·Phase 2·Recruiting·Listed Mar 2026
A Study of Brenipatide in Adult Participants With Schizophrenia
for Schizophrenia
32 locations incl. Little Rock
Sponsor: Eli Lilly and Company
Sex: All·Age: 18 - 55
Code: NCT07410507·Phase 2·Recruiting·Listed Feb 2026
A Study of Brenipatide in Participants With Opioid Use Disorder
for Opioid Use Disorder
38 locations incl. Phoenix
Sponsor: Eli Lilly and Company
Sex: All·Age: 18 - 75
Code: NCT07420283·Phase 2·Recruiting·Listed Feb 2026
A Phase 2 Study of Zelquistinel or Placebo for the Reduction of Symptoms of Major Depressive Disorder
for Major Depressive Disorder
30 locations incl. Phoenix
Sponsor: Syndeio Biosciences, Inc
Sex: All·Age: 18 - 64
Code: NCT07115329·Phase 2·Recruiting·Listed Aug 2025
A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder
for Major Depressive Disorder (MDD)
29 locations incl. Birmingham
Sponsor: Cybin IRL Limited
Sex: All·Age: 18 - 85
Code: NCT06793397·Phase 3·Recruiting·Listed Jan 2025
A Study to Evaluate the Effect of KarXT on Urological Safety
for Schizophrenia
13 locations incl. Little Rock
Sponsor: Bristol-Myers Squibb
Sex: All·Age: 18 - 65
Code: NCT07221877·Phase 4·Recruiting·Listed Oct 2025
Triage Survey for Psychiatry Research Eligibility
for Major Depressive Disorder
6 locations incl. Boston
Sponsor: Adams Clinical
Sex: All·Age: 18+
Code: NCT05800925·Recruiting·Listed Apr 2023
52-week Open Label Safety-Tolerability Study
for Schizophrenia
23 locations incl. Chandler
Sponsor: LB Pharmaceuticals Inc.
Sex: All·Age: 18 - 65
Code: NCT07369154·Phase 3·Recruiting·Listed Jan 2026
Get new-trial alerts for Adams Clinical, Philadelphia
We'll email you whenever a new clinical trial starts recruiting at this research site in Philadelphia, PA. Unsubscribe anytime.
More research sites in Philadelphia
- University of Pennsylvania (359 trials)
- Children's Hospital of Philadelphia (303 trials)
- Thomas Jefferson University Hospital (106 trials)
- Fox Chase Cancer Center (95 trials)
- Thomas Jefferson University (95 trials)
- Hospital of the University of Pennsylvania (88 trials)
- Temple University (41 trials)
- The Children's Hospital of Philadelphia (40 trials)
- Temple University Hospital (34 trials)
- University of Pennsylvania/Abramson Cancer Center (30 trials)
Is this your research site?
This page is built from public ClinicalTrials.gov records. If you work here, we can correct it, send you the patients who apply, and build you a free website from your real studies — verify it with your work email, or read what we do for research sites.
Explore more
Paid clinical trials in Philadelphia, PA · Pennsylvania clinical trials